✓
Open
21 Jun 2024
✓
Close
25 Jun 2024
3
Allotment
—
✓
Listing
Fri, Jun 28, 2024
Price Band
₹32 to ₹34
Issue Size
31,00,000 shares (agg. up to ₹11 Cr)
Lot Size
4,000 Shares
Listing Date
Fri, Jun 28, 2024
Latest GMP
₹70
Est. Gain
205.88%
✦ AI Insight
GMP Trend
28-06-2024₹70Est. ₹104+205.88%
27-06-2024₹70Est. ₹104+205.88%
26-06-2024₹50Est. ₹84+147.06%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 688.51x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 38.58 | 32.12 | 27.07 | 26.34 |
| Total Income | 25.29 | 22.96 | 21.19 | 25.06 |
| Profit After Tax | 2.40 | 0.96 | 0.09 | 0.30 |
| NET Worth | 15.18 | 8.52 | 7.56 | 7.47 |
| Reserves and Surplus | 6.58 | 2.52 | 1.56 | 1.47 |
| Total Borrowing | 12.66 | 11.80 | 10.25 | 9.59 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Quest Laboratories Ltd. | SME | ₹43.16 Cr | ₹97 | 23.03 | ₹147.35 | +51.91% | ₹82.00 |
| Zenith Drugs Ltd. | SME | ₹40.68 Cr | ₹79 | 18.4 | ₹105.15 | +33.10% | ₹48.85 |
| Sunrest Lifescience Ltd. | SME | ₹10.85 Cr | ₹84 | 12.33 | ₹79.80 | -5.00% | ₹39.00 |
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹9.00 |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹31.00 |
| Innova Captab Ltd. | Mainboard | ₹570.00 Cr | ₹448 | 31.64 | ₹541.40 | +20.85% | ₹1,171.80 |
| Blue Jet Healthcare Ltd. | Mainboard | ₹840.27 Cr | ₹346 | 37.49 | ₹413.40 | +19.48% | ₹581.50 |
| Valiant Laboratories Ltd. | Mainboard | ₹152.46 Cr | ₹140 | 15.71 | ₹170.25 | +21.61% | ₹114.13 |
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,470.50 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of expenses proposed to be incurred towards Product registration in the international markets | 3.00 |
| 2 | Plant updation and increase in production capacity | 2.25 |
| 3 | Funding working capital requirements of our Company | 4.00 |
| 4 | General corporate purpose | 0.39 |
About Medicamen Organics IPO
Updated on Aug 5, 2026
Contact Details
Medicamen Organics Ltd. Address10 Community CentreNo 2 Ashok Vihar Phase IINew Delhi, New Delhi, 110052+91-9818222845cs@mediorganics.inVisit Website